The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease

Heart and Vessels

Volumn 26, Issue 4, 2011, Pages 457-463

  Agirbasli, Mehmet ^a,c   Sumerkan, Mutlu Cagan ^a   Eren, Fatih ^a   Agirbasli, Deniz ^b  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

^c Ahmet Mithat Efendi Cad Akgun Apt 7/6 ^*  (Turkey)

Author keywords

Coronary artery disease severity; Lipids; LPL gene S447X polymorphism

Indexed keywords

CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EXERCISE TEST; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART PROTECTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIPID BLOOD LEVEL; LPL GENE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 79961236272     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0077-1     Document Type: Article

References (27)

1. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) 2007 European guidelines on cardiovascular disease prevention in clinical practice: executive summary Eur J Cardiovasc Prev Rehabil 14 Suppl 2 E1 E40
2. H Wang RH Eckel 2009 Lipoprotein lipase: from gene to obesity Am J Physiol Endocrinol Metab 297 E271 E288 19318514 10.1152/ajpendo.90920.2008 1:CAS:528:DC%2BD1MXhtVahsbnN
3. J Kobayashi A Nohara MA Kawashiri A Inazu J Koizumi K Nakajima H Mabuchi 2007 Serum lipoprotein lipase mass: clinical significance of its measurement Clin Chim Acta 378 7 12 17223095 10.1016/j.cca.2006.12.003 1:CAS:528: DC%2BD2sXit1Kitro%3D (Pubitemid 46241085)
4. J Kobayashi K Saito I Fukamachi K Taira K Takahashi H Bujo Y Saito 2001 Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation Horm Metab Res 33 412 416 11507678 10.1055/s-2001-16230 1:CAS:528:DC%2BD3MXmslSruro%3D (Pubitemid 32721523)
5. KA Dugi N Schmidt K Brandauer D Ramacher W Fiehn J Kreuzer 2002 Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease Atherosclerosis 163 127 134 12048130 10.1016/S0021-9150(01)00752-3 1:CAS:528:DC%2BD38XktFOns78%3D (Pubitemid 34615734)
6. RM Fisher SE Humphries PJ Talmud 1997 Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis Atherosclerosis 135 145 159 9430364 10.1016/S0021-9150(97)00199-8 1:CAS:528:DyaK2sXotVOjs7s%3D (Pubitemid 28015181)
7. V Murthy P Julien C Gagne 1996 Molecular pathobiology of the human lipoprotein lipase gene Pharmacol Ther 70 101 135 8843465 10.1016/0163-7258(96) 00005-8 1:CAS:528:DyaK28Xkt1Ols74%3D (Pubitemid 26233576)
8. Y Stein O Stein 2003 Lipoprotein lipase and atherosclerosis Atherosclerosis 170 1 9 12957676 10.1016/S0021-9150(03)00014-5 1:CAS:528:DC%2BD3sXmvVyiurs%3D (Pubitemid 37086704)
9. V Evans JJ Kastelein 2002 Lipoprotein lipase deficiency-rare or common? Cardiovasc Drugs Ther 16 283 287 12652096 10.1023/A:1021721707639 1:CAS:528:DC%2BD38XpslOhsLo%3D (Pubitemid 36174164)
10. M Merkel RH Eckel IJ Goldberg 2002 Lipoprotein lipase: genetics, lipid uptake, and regulation J Lipid Res 43 1997 2006 12454259 10.1194/jlr.R200015- JLR200 1:CAS:528:DC%2BD38XpslCqu7c%3D (Pubitemid 35471065)
11. J Rip MC Nierman CJ Ross JW Jukema MR Hayden JJ Kastelein ES Stroes JA Kuivenhoven 2006 Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation Arterioscler Thromb Vasc Biol 26 1236 1245 16574898 10.1161/01.ATV.0000219283.10832.43 1:CAS:528:DC%2BD28XksVGls74%3D (Pubitemid 44305366)
12. HH Wittrup A Tybjaerg-Hansen BG Nordestgaard 1999 Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis Circulation 99 2901 2907 10359734 1:STN:280:DyaK1M3ovFKqtg%3D%3D (Pubitemid 29258978)
13. SE Humphries V Nicaud J Margalef L Tiret PJ Talmud 1998 Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS) Arterioscler Thromb Vasc Biol 18 526 534 9555857 10.1161/01.ATV.18.4.526 1:CAS:528:DyaK1cXis1Wrsb4%3D (Pubitemid 28177891)
14. HE Henderson JJ Kastelein AH Zwinderman E Gagné JW Jukema PW Reymer BE Groenemeyer KI Lie AV Bruschke MR Hayden H Jansen 1999 Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins J Lipid Res 40 735 743 10191298 1:CAS:528:DyaK1MXitlGiu70%3D (Pubitemid 29173777)
15. SE Gagné MG Larson SN Pimstone EJ Schaefer JJ Kastelein PW Wilson JM Ordovas MR Hayden 1999 A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study Clin Genet 55 450 454 10450862 10.1034/j.1399-0004.1999.550609.x (Pubitemid 29335642)
16. BE Groenemeijer MD Hallman PW Reymer E Gagné JA Kuivenhoven T Bruin H Jansen KI Lie AV Bruschke E Boerwinkle MR Hayden JJ Kastelein 1997 Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group Circulation 95 2628 2635 9193431 1:CAS:528:DyaK2sXlsFKqur4%3D (Pubitemid 27255491)
17. AG Nikitin DA Chistiakov LO Minushkina DA Zateyshchikov VV Nosikov 2010 Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population Heart Vessels 25 229 236 20512451 10.1007/s00380-009-1159-9
18. E Kömürcü-Bayrak A Onat M Poda SE Humphries J Acharya G Hergenç N Çoban G Can N Erginel Ünaltuna 2007 The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks Clin Chim Acta 383 110 115 17555736 10.1016/j.cca.2007.05.007 (Pubitemid 47016460)
19. AT Alper H Hasdemir S Şahin E Öntürk A Akyol Z Nurkalem N Çakmak I Erdinler K Gürkan 2008 The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome Arch Turk Soc Cardiol 36 376 381
20. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2486 2497 10.1001/jama.285.19.2486
21. GG Gensini 1983 A more meaningful scoring system for determining the severity of coronary heart disease Am J Cardiol 51 606 6823874 10.1016/S0002-9149(83)80105-2 1:STN:280:DyaL3s7itlyitw%3D%3D (Pubitemid 13187192)
22. D Corella M Guillen C Saiz O Portoles A Sabater J Folch JM Ordovas 2002 Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus J Lipid Res 43 416 427 11893778 1:CAS:528:DC%2BD38XisVKnu7Y%3D (Pubitemid 34252272)
23. HH Wittrup BG Nordestgaard R Steffensen G Jensen A Tybjaerg-Hansen 2002 Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study Atherosclerosis 165 119 126 12208477 10.1016/S0021-9150(02)00183-1 1:CAS:528:DC%2BD38Xms1ygurw%3D (Pubitemid 35223173)
24. H Razzaghi CE Aston RF Hamman MI Kamboh 2000 Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels Hum Genet 107 257 267 11071388 10.1007/s004390000367 1:CAS:528:DC%2BD3cXotFShsL4%3D
25. K Iwasaki T Matsumoto H Aono H Furukawa K Nagamachi M Samukawa 2010 Distribution of coronary atherosclerosis in patients with coronary artery disease Heart Vessels 25 14 18 20091393 10.1007/s00380-009-1155-0
26. N Ishio Y Kobayashi Y Iwata H Kitahara K Fukushima T Asano T Nakayama N Kuroda I Komuro 2010 Ubiquitous atherosclerosis in coronary arteries without angiographically significant stenosis Heart Vessels 25 35 40 20091396 10.1007/s00380-009-1161-2
27. P Burchardt W Nowak A Gozdzicka-Jozefiak R Link T Grotowski A Wisniecka T Siminiak 2009 Presence of irregularity in region between -1115 and -784 nt in P1 promoter of Insulin-Like Growth Factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data Heart Vessels 24 254 259 19626396 10.1007/s00380-008-1116-z